Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010
Open accessAbstract
Summary Background Although stroke is the second leading cause of death worldwide, no comprehensive and comparable assessment of incidence, prevalence, mortality, disability, and epidemiological trends has been estimated for most regions. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to estimate the global and regional burden of stroke during 1990–2010. Methods We searched Medline, Embase, LILACS, Scopus, PubMed, Science Direct, Global Health Database, the WHO library, and WHO regional databases from 1990 to 2012 to identify relevant studies published between 1990 and 2010. We applied the GBD 2010 analytical technique (DisMod-MR), based on disease-specific, pre-specified associations between incidence, prevalence, and mortality, to calculate regional and country-specific estimates of stroke incidence, prevalence, mortality, and disability-adjusted life-years (DALYs) lost by age group (<75 years, ≥75 years, and in total) and country income level (high-income, and low-income and middle-income) for 1990, 2005, and 2010. Findings We included 119 studies (58 from high-income countries and 61 from low-income and middle-income countries). From 1990 to 2010, the age-standardised incidence of stroke significantly decreased by 12% (95% CI 6–17) in high-income countries, and increased by 12% (–3 to 22) in low-income and middle-income countries, albeit non-significantly. Mortality rates decreased significantly in both high income (37%, 31–41) and low-income and middle-income countries (20%, 15–30). In 2010, the absolute numbers of people with first stroke (16·9 million), stroke survivors (33 million), stroke-related deaths (5·9 million), and DALYs lost (102 million) were high and had significantly increased since 1990 (68%, 84%, 26%, and 12% increase, respectively), with most of the burden (68·6% incident strokes, 52·2% prevalent strokes, 70·9% stroke deaths, and 77·7% DALYs lost) in low-income and middle-income countries. In 2010, 5·2 million (31%) strokes were in children (aged <20 years old) and young and middle-aged adults (20–64 years), to which children and young and middle-aged adults from low-income and middle-income countries contributed almost 74 000 (89%) and 4·0 million (78%), respectively, of the burden. Additionally, we noted significant geographical differences of between three and ten times in stroke burden between GBD regions and countries. More than 62% of new strokes, 69·8% of prevalent strokes, 45·5% of deaths from stroke, and 71·7% of DALYs lost because of stroke were in people younger than 75 years. Interpretation Although age-standardised rates of stroke mortality have decreased worldwide in the past two decades, the absolute number of people who have a stroke every year, stroke survivors, related deaths, and the overall global burden of stroke (DALYs lost) are great and increasing. Further study is needed to improve understanding of stroke determinants and burden worldwide, and to establish causes of disparities and changes in trends in stroke burden between countries of different income levels. Funding Bill & Melinda Gates Foundation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 48 cited sources checked · 0 supported · 0 flagged
- Findingown data
The global increase in stroke incidence among people aged 20-64 was mostly attributable to an 18% (10-25) significant increase in low-income and middle-income countries.
“mostly attributable to an 18% (10–25) significant increase in low-income and middle-income countries.”
Quote in the paperNot a substantial claim - Findingown data
Globally, stroke incidence in people aged 20-64 increased significantly by 25% (13-33) between 1990 and 2010.
“Globally, for 1990–2010, we noted a 25% (13–33) significant increase in stroke incidence in people aged 20–64 years”
Quote in the paperNot a substantial claim - Findingown data
In 2010, the number of stroke survivors aged 75 years and older in high-income countries exceeded that in low-income and middle-income countries by 40%.
“the number of stroke survivors aged 75 years and older in high-income countries exceeded the number in low-income and middle-income countries by 40%”
Quote in the paperNot a substantial claim - Findingown data
In 2010, country-level stroke mortality ranged from 27 per 100,000 person-years in France to 264 in Afghanistan.
“mortality rates, ranging from 27 cases (France) to 264 cases (Afghanistan) per 100 000 person-years”
Quote in the paperNot a substantial claim - Findingown data
Incidence and prevalence increased significantly with age in all regions.
“Incidence and prevalence increased significantly with age in all regions (appendix)”
Quote in the paperNot a substantial claim
- Findingown data
From 1990 to 2010, the absolute number of incident strokes increased by 68% globally.
“noticeable increases took place in the absolute numbers of people with incident stroke (a 68% increase)”
Quote in the paperNot a substantial claim - Findingown data
Increases in incidence, mortality, and DALYs lost with age were steeper in low-income and middle-income countries.
“but steeper increases in incidence, mortality, and DALYs lost were shown in low-income and middle-income countries”
Quote in the paperNot a substantial claim - Findingown data
Across GBD regions, the percentage change in DALYs lost per 100,000 people ranged from −50·4% to −0·74%.
“Percent change in DALYs lost per 100 000 people in GBD regions varied from −50·4% to −0·74% (figure 4).”
Quote in the paperNot a substantial claim - Findingown data
Stroke incidence decreased in high-income Asia Pacific.
“but incidence decreased in high-income Asia Pacific (rates remained very high in eastern Europe; figure 1 and appendix).”
Quote in the paperNot a substantial claim - Findingown data
From 1990 to 2010, the absolute number of DALYs lost due to stroke increased by 12% globally.
“and DALYs lost (12%; table 1)”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
- Findingown data
Stroke burden varied significantly across GBD regions.
“We noted significant geographical variations in stroke burden by GBD region (figures 1–3 and appendix).”
Quote in the paperNot a substantial claim - Findingown data
In 2010, 5.2 million (31%) strokes occurred in children and young and middle-aged adults younger than 65 years.
“In 2010, 5·2 million (31%) strokes were in children (aged <20 years) and young and middle-aged adults (20–64 years)”
Quote in the paperNot a substantial claim - Findingown data
Globally, stroke mortality rate decreased significantly by 25% between 1990 and 2010.
“there was a significant 25% reduction in mortality rate”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- Findingown data
Age-specific incidence, mortality, and DALYs lost were significantly greater in low-income and middle-income countries than in high-income countries.
“Age-specific incidence, mortality, and DALYs lost in low-income and middle-income countries were significantly greater than those in high-income countries”
Quote in the paperSubstantial claim - Findingown data
Mortality-to-incidence ratio decreased significantly by 27% (14-38) in low-income and middle-income countries.
“and 27% [14–38])”
Quote in the paperNot a substantial claim - Findingown data
The increase in prevalence with age was steeper in high-income countries.
“and a steeper increase in prevalence was shown in high-income countries (appendix).”
Quote in the paperNot a substantial claim - Findingown data
The mean age of people with incident stroke worldwide has not significantly changed in the past two decades.
“Although the mean age of people with incident stroke worldwide has not significantly changed in the past two decades”
Quote in the paperNot a substantial claim - Findingown data
In high-income countries, the greatest reduction in mortality-to-incidence ratio was in people younger than 75 (32% decrease) compared with a 21% reduction in people aged 75 and older.
“The greatest reduction in mortality-to-incidence ratios was in people younger than 75 years in high-income countries (32% decrease) compared with a 21% reduction in people aged 75 years and older”
Quote in the paperNot a substantial claim - Findingown data
Stroke mortality rate decreased significantly by 20% (15-30) in low-income and middle-income countries.
“and 20% [15–30] in low-income and middle-income countries)”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- Findingown data
The mean age of fatal strokes in low-income and middle-income countries was more than 8 years younger than in high-income countries.
“The mean age that people had fatal strokes in low-income and middle-income countries was more than 8 years younger than that in high-income countries”
Quote in the paperNot a substantial claim - Findingown data
In 2010, age-standardised stroke mortality rates in people aged 75 years and older in low-income and middle-income countries exceeded those in high-income countries by 33%.
“Age-standardised rates of stroke mortality in people aged 75 years and older in low-income and middle-income countries exceeded mortality rates by 33% in the same age group of people living in high-income countries”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- Findingown data
In 2010, DALYs lost in people aged 75 years and older in low-income and middle-income countries exceeded those in high-income countries by less than two times.
“whereas in people aged 75 years and older, DALYs lost in low-income and middle-income countries exceeded those lost in high-income countries by less than two times”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
- Findingown data
From 1990 to 2010, age-standardised stroke incidence decreased significantly by 12% (95% CI 6-17) in high-income countries.
“a 12% [95% CI 6%–17%] statistically significant decrease in high-income countries”
Quote in the paperNot a substantial claim - Findingown data
Age-specific prevalence was significantly greater in high-income countries than in low-income and middle-income countries.
“but age-specific prevalence was significantly greater in high-income countries (appendix).”
Quote in the paperNot a substantial claim - Findingown data
In high-income countries, age-standardised stroke incidence decreased most in people aged 75 years and older (16% vs 9.1% in younger people).
“In high-income countries, age-standardised rates of stroke incidence were most significantly decreased in people aged 75 years and older (16% vs 9·1% in younger people”
Quote in the paperNot a substantial claim - Findingown data
In 2010, 31% of all incident strokes were in adults aged 20-64.
“In 2010, children and youths (aged <20 years) and young and middle-aged adults (20–64 years) constituted 0·5% and 31%, respectively, of all people with incident stroke”
Quote in the paperNot a substantial claim - Findingown data
In high-income countries, age-standardised stroke mortality decreased by 36-39% in both younger and older people.
“Age-standardised mortality rates in high-income countries significantly decreased by a similar proportion in younger and older people (by 36–39%”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- Findingown data
Stroke prevalence increased significantly by 27% (19-43) in high-income countries between 1990 and 2010.
“Stroke prevalence increased significantly by 27% (19–43) in high-income countries only”
Quote in the paperNot a substantial claim - Findingown data
From 1990 to 2010, the absolute number of stroke survivors increased by 84% globally.
“stroke survivors (84%)”
Quote in the paperNot a substantial claim - Findingown data
In 2010, country-level stroke incidence ranged from 60 per 100,000 person-years in Kuwait to 504 in Lithuania.
“ranging in 2010 from 60 cases (Kuwait) to 504 cases (Lithuania) per 100 000 person-years”
Quote in the paperNot a substantial claim - Findingown data
For all study periods, stroke prevalence was lowest in sub-Saharan Africa, northern Africa, and the Middle East.
“For all study periods, stroke prevalence was lowest in sub-Saharan Africa, northern Africa, and the Middle East regions (appendix).”
Quote in the paperNot a substantial claim - Findingown data
Mortality-to-incidence ratios decreased in all GBD regions except eastern Europe, south Asia, and high-income Asia Pacific, where they remained largely unchanged.
“Mortality-to-incidence ratios decreased in all GBD regions, except for eastern Europe, south Asia, and high-income Asia Pacific, where they remained largely unchanged (figure 3 and appendix).”
Quote in the paperNot a substantial claim - Findingown data
In 2010, there were almost 30% more stroke survivors younger than 75 in low-income and middle-income countries than in high-income countries.
“there were almost 30% more survivors younger than 75 years in low-income and middle-income countries than in high-income countries”
Quote in the paperNot a substantial claim - Findingown data
Globally, there was no significant change in age-standardised stroke incidence between 1990 and 2010.
“Although overall we noted no significant change in age-standardised incidence of stroke between 1990 and 2010”
Quote in the paperNot a substantial claim - Findingown data
Significant increases occurred in the mean age of incident, prevalent, and fatal strokes in both high-income and low-income and middle-income countries.
“a significant increase took place in the mean age of incident, prevalent, and fatal strokes in both high-income and low-income and middle-income countries”
Quote in the paperNot a substantial claim - Findingown data
In 2010, age-standardised stroke mortality rates in people younger than 75 in low-income and middle-income countries exceeded those in high-income countries by 212%.
“and by 212% for the younger than 75 years population”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- Findingown data
Of the strokes in people younger than 65 in 2010, young and middle-aged adults in low-income and middle-income countries contributed 4.0 million (78%).
“and 4·0 million (78%), respectively, of the burden.”
Quote in the paperNot a substantial claim - Findingown data
In 2010, 43% of all prevalent strokes were in adults aged 20-64.
“1·1% and 43% of all prevalent strokes”
Quote in the paperNot a substantial claim - Findingown data
In 2010, mortality-to-incidence ratios in people aged 75 years and older in low-income and middle-income countries exceeded those in high-income countries by 12%.
“but in those aged 75 years and older, the excess was only 12%”
Quote in the paperNot a substantial claim - Findingown data
In 2010, the number of people younger than 75 with incident stroke in low-income and middle-income countries was more than three times that in high-income countries.
“the number of people younger than 75 years with incident stroke in low-income and middle-income countries is more than three times that in high-income countries”
Quote in the paperNot a substantial claim - Findingown data
In 2010, mortality-to-incidence ratios in people younger than 75 in low-income and middle-income countries were 37% greater than in high-income countries.
“Mortality to incidence ratios in people younger than 75 years in low-income and middle-income countries were significantly higher at 37% greater than those in high-income countries”
Quote in the paperNot a substantial claim - Findingown data
DALYs lost due to stroke decreased significantly by 36% (30-40) in high-income countries.
“DALYs lost (36% [30–40]”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
- Findingown data
In 2010, DALYs lost in people younger than 75 in low-income and middle-income countries exceeded those in high-income countries by almost five times.
“the number of DALYs lost in people younger than 75 years in low-income and middle-income countries exceeded those lost in high-income countries by almost five times”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
- Findingown data
Globally in 2010, the mortality-to-incidence ratio for stroke was 0.35.
“Globally, in 2010, the mortality-to-incidence ratio was 0·35”
Quote in the paperNot a substantial claim - Findingown data
In 2010, 55% of stroke deaths occurred in people aged 75 years and older.
“55% of stroke deaths (73% in high-income countries and 47% in low-income and middle-income countries)”
Quote in the paperNot a substantial claim - Findingown data
From 1990 to 2010, the absolute number of stroke-related deaths increased by 26% globally.
“stroke-related deaths (26%)”
Quote in the paperNot a substantial claim - Findingown data
Stroke mortality rate decreased significantly by 37% (31-41) in high-income countries.
“(37% [31–41] in high-income countries”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- Findingown data
DALYs lost due to stroke decreased significantly by 22% (18-32) in low-income and middle-income countries.
“and 22% [18–32], respectively)”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
- Findingown data
The mean age of patients with incident and prevalent stroke in high-income countries was more than 5 years greater than in low-income and middle-income countries.
“The mean age of patients with incident and prevalent stroke in high-income countries was more than 5 years greater than that in low-income and middle-income countries”
Quote in the paperNot a substantial claim - Findingown data
In high-income countries, stroke prevalence increased significantly by 23-25% in both younger and older age groups.
“whereas prevalence increased significantly by a similar proportion (23–25%) in people of both age groups”
Quote in the paperNot a substantial claim - Findingown data
Stroke prevalence increased noticeably in high-income North America, from 495-750 per 100,000 in 1990 to 595-1067 in 2010.
“Prevalence increased noticeably in high-income North America (from 495–750 per 100 000 people in 1990 to 595–1067 in 2010)”
Quote in the paperNot a substantial claim - Findingown data
Stroke prevalence increased in western and eastern Europe, east and southeast Asia, Australasia, and high-income Asia Pacific, from 355-495 per 100,000 in 1990 to 394-595 in 2010.
“and western and eastern Europe, east and southeast Asia, Australasia, and high-income Asia Pacific regions (from 355–495 in 1990 to 394–595 in 2010; appendix).”
Quote in the paperNot a substantial claim - Findingown data
The proportion of stroke burden is greater overall in individuals younger than 75 years than in those who are older, especially in low-income and middle-income regions.
“however, our data show that the proportion of stroke burden is greater overall in individuals younger than 75 years than in those who are older, especially in low-income and middle-income regions.”
Quote in the paperSubstantial claim - Findingreasoning
The significantly greater prevalence of stroke in high-income than in low-income and middle-income countries is associated with an inverse association between stroke prevalence and stroke mortality and DALYs lost.
“The significantly greater prevalence of stroke in high-income than in low-income and middle-income countries is associated with an inverse association between prevalence of stroke and stroke mortality and DALYs lost (significantly lower stroke mortality and DALYs lost in high-income vs low-income and middle-income countries).”
Quote in the paperSubstantial claim - Findingown data
Most of the global stroke burden is in low-income and middle-income countries.
“with most of the burden in low-income and middle-income countries.”
Quote in the paperSubstantial claim - Findingown data
The proportion of stroke in people younger than 65 years is substantial, especially in low-income and middle-income countries.
“the proportion of stroke in people younger than 65 years is substantial, especially in low-income and middle-income countries”
Quote in the paperNot a substantial claim - Findingown data
The mean age of people with stroke is increasing in countries of both income levels.
“Our study also showed that although the mean age of people with stroke is increasing in countries of both income levels”
Quote in the paperNot a substantial claim - Interpretationnone given
This study is the first to report global stroke burden in terms of incidence, prevalence, mortality, DALYs lost, and mortality-to-incidence ratios across GBD regions and all countries in 1990, 2005, and 2010, and for all age groups.
“This study is the first to report the global burden of stroke in terms of incidence, prevalence, mortality, DALYs lost, and mortality-to-incidence ratios across GBD regions and all countries in 1990, 2005, and 2010, and for all age groups of the population.”
Quote in the paperSubstantial claim - Interpretationcitation
Differences in the prevalence and significance of stroke risk factors, and in access to health services and control of those risk factors, are likely to account for large geographical variations in stroke incidence.
“Differences in the prevalence and significance of stroke risk factors,21–23 and in the accessibility of health services and level of control of these risk factors,24 are likely to account for the large geographical variations in stroke incidence.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [21] Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
- cites [22] Putaala, 2012, Demographic and geographic vascular risk factor differences in European young adults with ischemic stroke: the 15 Cities Young Stroke study, Stroke source
Not checked in the free run.
- cites [23] O'Donnell, 2010, Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case–control study, Lancet source
Not checked in the free run.
- cites [24] 2011
Not checked in the free run.
- Premisecitation
Similar reductions in stroke mortality have taken place in some low-income and middle-income countries.
“Although similar reductions in stroke mortality have taken place in some low-income and middle-income countries,29,30”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [29] Andrè, 2006, Progressive decline in stroke mortality in Brazil from 1980 to 1982, 1990 to 1992, and 2000 to 2002, Stroke source
Not checked in the free run.
- cites [30] Stringhini, 2012, Declining stroke and myocardial infarction mortality between 1989 and 2010 in a country of the African region, Stroke source
Not checked in the free run.
- Premisereasoning
Stroke diagnosis is unlikely to have changed between 1990 and 2010 because most diagnoses were based on clinical WHO criteria and, when imaging was available, CT verification of pathological subtypes.
“Stroke diagnosis is unlikely to have changed between 1990 and 2010 because most diagnoses have been based on clinical (WHO) criteria and, when imaging was available, for verification of pathological subtypes on CT images.”
Quote in the paperNot a substantial claim - Interpretationreasoning
If trends in smoking and other stroke risk factors continue unchecked, stroke burden will increase further in low-income and middle-income countries.
“because, if these trends continue and are left unchecked, further increases in stroke burden will take place in low-income and middle-income countries.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Trends in smoking and other stroke risk factors in the developing world will continue unchecked.
- Study design and conductcitation
The consistency of the study's estimates of stroke incidence, prevalence, and mortality-to-incidence ratios in both low-income and middle-income and high-income countries with two previous systematic reviews based on more rigorous ideal population-based studies corroborates the findings.
“The consistency of our estimates of stroke incidence, prevalence, and mortality-to-incidence ratios in both low-income and middle-income and high-income countries with those reported in two previous systematic reviews based on methodologically more rigorous ideal population-based studies of stroke incidence and prevalence3,46 corroborates our findings.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [3] Feigin, 2009, Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review, Lancet Neurol source
Not checked in the free run.
- cites [46] Feigin, 2003, Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century, Lancet Neurol source
Not checked in the free run.
- Interpretationreasoning
Worldwide, population ageing, overall population growth, reduced stroke case-fatality, and epidemiological transition in low-income and middle-income countries, leading to more stroke risk factors, are likely causes of increases in incident strokes, survivors, and DALYs lost.
“Worldwide, ageing of the population, overall population growth, reduced stroke case-fatality and epidemiological transition in low-income and middle-income countries, resulting in increases in the prevalence of stroke risk factors, are likely to be the cause of increases in the number of incident strokes, stroke survivors, and DALYs lost.”
Quote in the paperSubstantial claim - Interpretationcitation
The similar decline in stroke incidence and mortality suggests that changes in mortality rates are most likely attributable to corresponding changes in incidence.
“In line with previous findings,3 the similar pattern of decline in stroke incidence and mortality suggests that changes in mortality rates are most likely to be attributable to the corresponding changes in incidence.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Feigin, 2009, Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review, Lancet Neurol source
Not checked in the free run.
- Interpretationcitation
Substantial geographical differences in stroke burden by GBD region and country income level are likely attributable to differences in national income per person.
“Furthermore, we noted a substantial geographical difference in stroke burden by GBD regions and country income level, which is likely to be attributed to differences in the national income per person.19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Johnston, 2009, Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling, Lancet Neurol source
Not checked in the free run.
- Interpretationreasoning
In high-income countries, good health services and stroke prevention and care strategies are the most likely explanations for greater reductions in stroke incidence, mortality, mortality-to-incidence ratios, and DALYs lost.
“Within high-income countries, good health services and strategies for stroke prevention and care (eg, smoking cessation, control of blood pressure, and acute stroke units) are the most likely explanations for the greater reduction in stroke incidence, mortality, mortality-to-incidence ratios, and DALYs lost”
Quote in the paperSubstantial claim - Study design and conductreasoning
The study allowed studies of both high and lower methodological quality from low-income and middle-income countries, rather than only high-quality studies as for high-income countries.
“As such, we allowed studies of both high and lower methodological quality from these countries, rather than only studies of high methodological quality as for high-income countries.”
Quote in the paperSubstantial claim - Study design and conductreasoning
There was substantial regional heterogeneity in the stroke data, particularly from low-income and middle-income countries.
“Additionally, there was substantial regional heterogeneity of the stroke data, particularly that from low-income and middle-income countries.”
Quote in the paperSubstantial claim - Interpretationcitation
The high and increasing DALYs lost due to stroke are consistent with the GBD 2010 theme that disability is causing an increasing fraction of disease burden as demographics and epidemiology evolve.
“The high and increasing DALYs lost due to stroke are consistent with one of GBD 2010’s recurring themes: disability is causing an increasing fraction of the burden of disease as demographics and epidemiology evolve.2,10”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [2] Murray, 2012, Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
- cites [10] Vos, 2012, Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
- Study design and conductnone given
A main limitation is scarcity of high-quality epidemiological stroke data from low-income and middle-income countries, especially for stroke incidence and mortality.
“The main limitations include a scarcity of high-quality epidemiological stroke data from low-income and middle-income countries, especially for stroke incidence and mortality.”
Quote in the paperSubstantial claim - Interpretationreasoning
Insufficient high-quality data from low-income and middle-income countries might account for some differences noted in stroke epidemiological characteristics and burden between countries of different income levels.
“Insufficient high-quality data from low-income and middle-income countries might account for some of the differences noted in the epidemiological characteristics of stroke”
Quote in the paperNot a substantial claim
- May combine two claims. 39
- Classified as probably not a substantial claim. 28
- The quote only partly states this claim. 5
May combine two claims.
Findingown dataStroke mortality increased in sub-Saharan Africa, south Asia, and central and Latin America.
“Mortality increased in sub-Saharan Africa, south Asia, and central and Latin America, but decreased in high-income North America, western and central Europe, north Africa and the Middle East, Australasia, and high-income Asia Pacific”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, there were an estimated 16.9 million incident strokes worldwide.
“an estimated 16·9 million cases of incident stroke took place worldwide”
- Also stated in: § Findings · plain
“the absolute numbers of people with first stroke (16·9 million)”
Quote in the paperNot a substantial claim- Also stated in: § Findings · plain
Probably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown dataIn 2010, country-level DALYs lost ranged from 398 per 100,000 in Australia to 5227 in Afghanistan.
“DALYs lost, ranging from 398 (Australia) to 5227 (Afghanistan) per 100 000 people”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 22% of all stroke deaths were in adults aged 20-64.
“0·7% and 22% of all stroke deaths”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 69% of incident strokes occurred in low-income and middle-income countries.
“(69% in low-income and middle-income countries)”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataIn 2010, age-standardised stroke incidence rates in low-income and middle-income countries exceeded those in high-income countries by 23%.
“Presently, age-standardised rates of stroke incidence in low-income and middle-income countries exceed those in high-income countries by 23%”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, there were an estimated 33.0 million prevalent stroke cases worldwide.
“33·0 million prevalent stroke cases”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 28% of DALYs lost occurred in people aged 75 years and older.
“28% of DALYs lost (46% in high-income countries and 23% in low-income and middle-income countries) were in people aged 75 years and older”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataStroke mortality decreased in high-income North America, western and central Europe, north Africa and the Middle East, Australasia, and high-income Asia Pacific.
“but decreased in high-income North America, western and central Europe, north Africa and the Middle East, Australasia, and high-income Asia Pacific”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn low-income and middle-income countries, age-standardised incidence and prevalence increased almost equally (9-10%) in younger and older people, but the increases were not significant.
“In low-income and middle-income countries, age-standardised incidence and prevalence increased almost equally (9–10%) in younger and older people, but the increases were not significant”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe largest reductions in DALYs lost occurred in west and central sub-Saharan Africa, eastern Europe, and central, south, and southeast Asia.
“The most marked reductions in DALYs lost were in west and central sub-Saharan Africa; eastern Europe; and central, south, and southeast Asia (figure 4 and appendix).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn high-income countries, DALYs lost fell by 36% in people younger than 75 and by 63% in older people.
“whereas DALYs lost fell by 36% in people younger than 75 years and by 63% in older people”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
May combine two claims.
Findingown dataIn low-income and middle-income countries, significant reductions occurred in age-standardised stroke mortality (24%), DALYs lost (24%), and mortality-to-incidence ratios (32%) in people younger than 75 compared with older people (16%, 17%, and 23% respectively).
“Most striking were significant reductions in rates of age-standardised stroke mortality (24%), DALYs lost (24%), and mortality-to-incidence ratios (32%) in people younger than 75 years compared with older people (16%, 17%, and 23% respectively”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
- The authors state this as an assumption: A hierarchy of risk exists that would be retained in the model.
- The authors state this as an assumption: Comorbid diseases have independent probabilities.
- The authors state this as an assumption: Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
- The authors state this as an assumption: The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 30% of prevalent strokes occurred in people aged 75 years and older.
“30% of prevalent strokes (40% in high-income countries and 22% in low-income and middle-income countries)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOf 16,558 potentially eligible studies, 119 articles were selected for final analysis, including 58 from high-income countries and 61 from low-income and middle-income countries.
“Of 16 558 potentially eligible studies undertaken in 1990–2010, we selected 119 articles for final analysis: 58 from high-income countries and 61 from low-income and middle-income countries.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 78% of DALYs lost were in low-income and middle-income countries.
“(78% in low-income and middle-income countries; table 1)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, there were an estimated 5.9 million stroke deaths worldwide.
“5·9 million stroke deaths”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataStroke prevalence increased by 8.5% (-13 to 34) in low-income and middle-income countries, but the increase was not significant.
“the 8·5% (−13 to 34) increase in low-income and middle-income countries was not significant.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn 2010, the mortality-to-incidence ratio was 0.32 in high-income countries and 0.36 in low-income and middle-income countries.
“(0·32 in high-income countries and 0·36 in low-income and middle-income countries; table 1)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 71% of stroke deaths occurred in low-income and middle-income countries.
“(71% in low-income and middle-income countries)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe most striking increases in number of stroke survivors (113%), DALYs lost (31%), and stroke-related deaths (36%) occurred in people aged 75 years and older.
“The most striking increases in the number of stroke survivors (113%), DALYs lost (31%), and stroke-related deaths (36%) were in people aged 75 years and older”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, country-level stroke prevalence ranged from 82 survivors per 100,000 in Burundi to 1187 in Canada.
“prevalence, ranging from 82 stroke survivors (Burundi) to 1187 survivors (Canada) per 100 000 people”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataFrom 1990 to 2010, age-standardised stroke incidence increased by 12% (-3 to 22) in low-income and middle-income countries, but the increase was not significant.
“and a 12% [−3 to 22] non-significant increase in low-income and middle-income countries”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataStroke incidence increased in sub-Saharan Africa (central, east, southern, and west), the Middle East, southeast Asia, central and Latin America, and south and east Asia.
“By GBD regions, increases were shown in stroke incidence in sub-Saharan Africa (central, east, southern, and west), the Middle East, southeast Asia, central and Latin America, and south and east Asia, but incidence decreased in high-income Asia Pacific”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataOf the strokes in people younger than 65 in 2010, children in low-income and middle-income countries contributed almost 74,000 (89%).
“to which children and young to middle-age adults in low-income and middle-income countries contributed almost 74 000 (89%)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). The quote only partly states this claim.
Findingown dataIn 2010, there were an estimated 102.2 million DALYs lost worldwide.
“102·2 million DALYs lost”
Quote in the paperNot a substantial claimThe quote only partly states this claim.
Findingown dataMortality-to-incidence ratio decreased significantly by 23% (14-29) in high-income countries.
“mortality-to-incidence ratio (23% [14–29]”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, 52% of prevalent stroke cases were in low-income and middle-income countries.
“(52% in low-income and middle-income countries)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn 2010, country-level mortality-to-incidence ratios ranged from 0.11 in Iran to 1.35 in Afghanistan.
“and in mortality-to-incidence ratios, ranging from 0·11 (Iran) to 1·35 (Afghanistan).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationIn the past two decades there was a trend towards incident stroke occurring later in life, probably because of an ageing population.
“Although in the past two decades there was a trend towards occurrence of incident stroke later in life, probably because of an ageing population,35”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] Cairncross, 2007, Economics: age, health and wealth, Nature source
Not checked in the free run.
May combine two claims.
FindingreasoningEven low-income and middle-income regions with relatively low stroke incidence and prevalence, such as sub-Saharan Africa, have high stroke mortality rates and a low rate of reduction in DALYs lost.
“Even low-income and middle-income regions with a relatively low stroke incidence and prevalence, such as sub-Saharan Africa, have high stroke mortality rates and a low rate of reduction in DALYs lost.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataStroke mortality decreased in low-income and middle-income countries, but the decrease was not significant.
“our findings of the decrease in mortality in low-income and middle-income countries, although not significant, were unexpected.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataStroke mortality rates and mortality-to-incidence ratios decreased over the past two decades.
“Our findings show that although stroke mortality rates and mortality-to-incidence ratios have decreased in the past two decades”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningIn low-income and middle-income countries, stroke incidence has increased, and mortality-to-incidence ratios and DALYs lost are higher than in high-income countries.
“For example, in these countries, stroke incidence has increased, and mortality-to-incidence ratios and DALYs lost are higher than in high-income countries.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataMore than 83,000 children and youths aged 20 years and younger are affected by stroke annually.
“and more than 83 000 children and youths aged 20 years and younger are affected by stroke annually.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataWorldwide in 2010, roughly 10% of deaths and about 4% of DALYs were due to stroke.
“Worldwide in 2010, roughly 10% of the 52 769 700 deaths1 and about 4% of the 2 490 385 000 DALYs2 were due to stroke.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Lozano, 2012, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
- cites [2] Murray, 2012, Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
May combine two claims.
Findingown dataThis study is the first to show that age-specific stroke burden is significantly greater in low-income and middle-income countries than in high-income countries, while age-specific stroke prevalence is significantly greater in high-income countries.
“Our study is the first to show that the age-specific burden of stroke in low-income and middle-income countries is significantly greater than that in high-income countries, whereas the age-specific prevalence of stroke is significantly greater in high-income countries.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe proportion of young people aged under 20 years and young and middle-aged adults aged 20-64 years affected by stroke increased.
“the pro portion of young people (aged <20 years) and young and middle-aged adults (20–64 years) affected by stroke increased.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe absolute global burden of stroke-people affected each year, survivors, related deaths, and DALYs lost-is large and increasing.
“the global burden of stroke in terms of the absolute number of people affected every year, stroke survivors, related deaths, and DALYs lost are great and increasing”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStroke was the second leading cause of death worldwide in 2010 according to GBD 2010.
“Estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD 2010) ranked stroke as the second most common cause of death1”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [1] Lozano, 2012, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationStroke was the third leading cause of DALYs worldwide in 2010 according to GBD 2010.
“and the third most common cause of disability-adjusted life-years (DALYs)2 worldwide in 2010.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [2] Murray, 2012, Disability-adjusted life-years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationFor low-income and middle-income countries, less rigorous case ascertainment was permitted when no other relevant data were available.
“We allowed less rigorous case ascertainment for studies from low-income and middle-income countries in which no other relevant data were otherwise available”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [5] Bennett, 2012, Methodology of the global and regional burden of stroke study, Neuroepidemiology source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe same prior review found a 42% decrease in stroke incidence in high-income countries over the past four decades.
“by contrast with high-income countries where a 42% decrease in incidence has taken place in the past four decades.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Feigin, 2009, Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review, Lancet Neurol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationFor high-income countries, incidence studies were required to have complete ascertainment of stroke cases with multiple overlapping sources.
“Incidence studies from high-income countries had to include complete ascertainment of stroke cases (ie, admitted or not admitted to hospital, fatal and non-fatal) with several overlapping sources of information”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Feigin, 2004, How to study stroke incidence, Lancet source
Not checked in the free run.
May combine two claims.
Study design and conductown dataHigh methodological quality studies (rating 4-5) made up 55 (95%) of high-income country studies and 14 (23%) of low-income and middle-income country studies.
“Studies of a high methodological quality (quality rating 4–5) constituted 55 (95%) of the studies in high-income countries and 14 (23%) of those in low-income and middle-income countries.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductcitationThe analysis included only studies that used WHO's stroke definition, reported case ascertainment methods, distinguished first-ever from recurrent stroke, and reported age-specific epidemiological parameter and population denominator.
“we included only studies that used WHO’s definition of stroke,6 that reported methods for ascertainment stroke cases, that distinguished between first-ever and recurrent stroke (only incident strokes were included in these analyses), and that reported an age-specific epidemiological parameter of interest and the population denominator”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [6] Aho, 1980, Cerebrovascular disease in the community: results of a WHO collaborative study, Bull World Health Organ
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA prior systematic review of population-based stroke incidence studies from 28 countries found increasing incidence in low-income and middle-income countries.
“A previous systematic review3 of population-based studies of stroke incidence from 28 countries showed that incidence is increasing in low-income and middle-income countries”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Feigin, 2009, Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review, Lancet Neurol source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe sponsor had no role in study design, data collection, data analysis, data interpretation, or writing of the report.
“The sponsor of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationGBD 2010 developed statistical methods to address incomplete epidemiological data and produce comparable estimates of global burden for 291 diseases and injuries across 21 world regions.
“The GBD 2010 investigators developed statistical methods4 to address incomplete epidemiological data and provide the most complete and com parable estimates of the global burden of 291 diseases and injuries in all countries grouped into 21 world regions”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [4] Murray, 2012, GBD 2010: design, definitions, and metrics, Lancet source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe absolute number of people who have a stroke every year, stroke survivors, related deaths, and the overall global burden of stroke are great and increasing.
“the absolute number of people who have a stroke every year, stroke survivors, related deaths, and the overall global burden of stroke (DALYs lost) are great and increasing.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGBD 2010 estimates showed that ischaemic heart disease and stroke were the two greatest causes of death between 1990 and 2010.
“Although the estimates from the GBD 2010 Study showed that ischaemic heart disease and stroke were the two greatest causes of death between 1990 and 2010,1,8”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [1] Lozano, 2012, Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
- cites [8] Wang, 2012, Age-specific and sex-specific mortality in 187 countries, 1970–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThe study probably underestimated stroke burden by excluding silent strokes and vascular dementia from the case definition and by not including accelerated long-term cognitive functional decline in disability estimation.
“There fore, we probably underestimated the burden of stroke by not including so-called silent strokes and vascular dementia in the case definition nor the effect of accelerated long-term cognitive functional decline in our estimation of disability.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationBecause of the worldwide diabetes epidemic and increasing prevalence of other cardiovascular risk factors in young adults and overall, especially in low-income and middle-income countries, the shift in stroke burden towards younger populations is likely to continue globally unless effective preventive strategies are urgently implemented.
“In view of the worldwide epidemic of diabetes38 and increasing prevalence of other cardiovascular risk factors in young adults39,40 and overall,41–45 especially in low-income and middle-income countries, the shift in stroke burden towards younger populations is likely to continue globally unless effective preventive strategies are urgently implemented.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [38] Danaei, 2011, National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants, Lancet source
Not checked in the free run.
- cites [39] 2012, Challenging age—old ideas about stroke, Lancet Neurol
Not checked in the free run.
- cites [40] de los Rios, 2012, Trends in substance abuse preceding stroke among young adults: a population-based study, Stroke source
Not checked in the free run.
- cites [41] Danaei, 2011, National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5·4 million participants, Lancet source
Not checked in the free run.
- cites [42] Farzadfar, 2011, National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3·0 million participants, Lancet source
Not checked in the free run.
- cites [43] Finucane, 2011, National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants, Lancet source
Not checked in the free run.
- cites [44] 2011, An epidemic of risk factors for cardiovascular disease, Lancet source
Not checked in the free run.
- cites [45] Anand, 2011, Stemming the global tsunami of cardiovascular disease, Lancet source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe paper did not find a strong parallel between changes in stroke incidence and mortality, suggesting that factors contributing to stroke incidence and mortality or their changes over time might differ.
“As in a previous study30 we did not note a strong parallel between changes in stroke incidence and mortality, suggesting that factors contributing to stroke incidence and mortality or their changes (including level of exposure to those factors) over time might be different.31”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [30] Stringhini, 2012, Declining stroke and myocardial infarction mortality between 1989 and 2010 in a country of the African region, Stroke source
Not checked in the free run.
- cites [31] Truelsen, 2003, Trends in stroke and coronary heart disease in the WHO MONICA Project, Stroke source
Not checked in the free run.
May combine two claims.
Study design and conductreasoningThis limitation should not have a marked effect on the estimates because standard methodological criteria for study selection were applied across the 20-year period and the quality of data was believed consistent for included studies.
“However, this limitation should not have a marked effect on our estimates because we applied standard methodological criteria for selection of studies across the 20 year study period and believe that the quality of data was consistent for included studies.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe prevalence of smoking and other risk factors for stroke is increasing in the developing world.
“The increasing prevalence of smoking20 and other risk factors21 for stroke in the developing world is particularly alarming”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [20] 2013
Not checked in the free run.
- cites [21] Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA worrisome trend towards increasing stroke incidence in young adults has been reported for some countries.
“A worrisome trend towards increasing stroke incidence in young adults has been reported for some countries.36,37”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] Kissela, 2012, Age at stroke: temporal trends in stroke incidence in a large, biracial population, Neurology source
Not checked in the free run.
- cites [37] Medin, 2004, Increasing stroke incidence in Sweden between 1989 and 2000 among persons aged 30 to 65 years: evidence from the Swedish Hospital Discharge Register, Stroke source
Not checked in the free run.
May combine two claims.
InterpretationreasoningTogether with increased mortality-to-incidence ratios in low-income and middle-income countries, the inverse prevalence-mortality association suggests that differences in acute stroke management are the likely explanation for prevalence differences, with less adequate management linked to greater case fatality and lower prevalence.
“Together with increased mortality-to-incidence ratios in low-income and middle-income countries, this finding suggests differences in the management of acute stroke as the likely explanation of differences in stroke prevalence, with less adequate stroke management being associated with a greater case fatality and subsequent lower levels of stroke prevalence.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataTogether with a significant increase in stroke incidence in young and middle-aged adults, these findings suggest that stroke should no longer be regarded as a disease of old age.
“In addition to a significant increase in the incidence of stroke in young and middle-aged adults, these findings suggest that stroke should no longer be regarded as a disease of old age.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationDifficulty in access to health care and restricted resources for acute stroke treatment, rehabilitation, and secondary prevention are likely to account for higher stroke mortality, mortality-to-incidence ratios, and DALYs lost, and lower stroke prevalence in low-income and middle-income countries than in high-income countries.
“Difficulty in access to health care, and restricted resources in terms of adequate acute stroke treatment, rehabilitation, and secondary stroke prevention (eg, anticoagulation for patients with ischaemic stroke with atrial fibrillation) are likely to account for higher stroke mortality, mortality-to-incidence ratios, and DALYs lost, and lower stroke prevalence in low-income and middle-income coun”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [19] Johnston, 2009, Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling, Lancet Neurol source
Not checked in the free run.
- cites [34] Norrving, 2013, The global burden of stroke and need for a continuum of care, Neurology
Not checked in the free run.
May combine two claims.
Study design and conductnone givenThis study was comprehensive in global coverage, based on the largest stroke epidemiological dataset to date, and was the first to provide systematic regional and country-specific estimates of stroke burden.
“This study was comprehensive in its global coverage, is based on the largest stroke epidemiological dataset to date, and is the first to provide systematic regional and country-specific estimates of stroke burden”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationWide geographical variations in stroke mortality rates, with significantly greater age-adjusted mortality and DALYs lost in low-income and middle-income countries than in high-income countries, have been reported elsewhere.
“Wide geographical variations in rates of stroke mortality,19,32,33 with significantly greater rates of age-adjusted mortality and DALYs lost in low-income and middle-income countries than in high-income countries,19 have also been reported elsewhere.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [19] Johnston, 2009, Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling, Lancet Neurol source
Not checked in the free run.
- cites [32] Sarti, 2000, International trends in mortality from stroke, 1968 to 1994, Stroke source
Not checked in the free run.
- cites [33] Sarti, 2003, Are changes in mortality from stroke caused by changes in stroke event rates or case fatality? Results from the WHO MONICA Project, Stroke source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe possibility of errors in calculations of stroke disability weights cannot be excluded.
“Although we cannot exclude the possibility of errors in calculations of stroke disability weights”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataSensitivity analyses for incomplete and poor-quality data and for settings with no data gave similar results, showing robustness of the stroke mortality estimates.
“The sensitivity analyses we undertook to assess the effects of incomplete and poor quality data , and for settings where no data were available, gave similar results, thus showing the robustness of estimates of stroke mortality.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIf current trends in stroke incidence, mortality, and DALYs continue, by 2030 there will be almost 12 million stroke deaths, 70 million stroke survivors, and more than 200 million DALYs lost globally.
“If these trends in stroke incidence, mortality, and DALYs continue, by 2030 there will be almost 12 million stroke deaths, 70 million stroke survivors, and more than 200 million DALYs lost globally.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Trends in stroke incidence, mortality, and DALYs will continue as observed.
May combine two claims.
Study design and conductown dataThe high correlation of disability weights across settings suggests a broadly shared set of common values for health losses due to stroke, increasing confidence in the reliability of the disability weight calculations.
“the high correlation of the weights across settings suggests that a broadly shared set of common values exists for health losses due to stroke, thus increasing our confidence in the reliability of our calculations of disability weights.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe reduction in stroke mortality in high-income countries is not surprising because it has been consistently reported in most countries of this income level.
“Although the reduction in stroke mortality in high-income countries is not surprising because it has been consistently reported in most countries of this income level,25–28”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [25] Vaartjes, 2013, Remarkable decline in ischemic stroke mortality is not matched by changes in incidence, Stroke source
Not checked in the free run.
- cites [26] Gillum, 2011, Ethnic and geographic variation in stroke mortality trends, Stroke source
Not checked in the free run.
- cites [27] Kunst, 2011, The decline in stroke mortality: exploration of future trends in 7 western European countries, Stroke source
Not checked in the free run.
- cites [28] Redon, 2011, Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure, Eur Heart J source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe paper's results reinforce earlier conclusions that stroke burden is growing globally and especially in low-income and middle-income countries.
“Therefore, our results reinforce the conclusions of the 1990, 2001, and GBD 2010 studies about the growing burden of stroke globally and in low-income and middle-income countries in particular (panel).”
Quote in the paperSubstantial claim
The paper relies on this without support.
No comprehensive and comparable assessment of stroke incidence, prevalence, mortality, disability burden, and recent epidemiological trends has been estimated for most world regions.
“However, no comprehensive and comparable assessment of stroke incidence, prevalence, mortality, disability burden (as measured by DALYs lost), and recent epidemiologic trends has been estimated for most world regions.”
The authors state this as an assumption.
The direction of effect of selected covariates on stroke mortality is plausible based on existing scientific literature.
“We selected a set of relevant covariates and assumed a plausible direction of effect on the basis of existing scientific literature (appendix).”
The authors state this as an assumption.
A hierarchy of risk exists that would be retained in the model.
“We assumed that a hierarchy of risk existed that would be retained in the model.”
The authors state this as an assumption.
Comorbid diseases have independent probabilities.
“assuming independent probabilities of comorbid diseases (eg, stroke plus diabetes).”
The authors state this as an assumption.
Disability is the same for haemorrhagic and ischaemic stroke during the hyperacute phase (1-3 days after event).
“We assumed the same disability for haemorrhagic and ischaemic stroke during the hyperacute phase (ie, 1–3 days after the event)”
The authors state this as an assumption.
The distribution of severity is similar based on GBD sequela definition and Rankin Scale categories.
“We assumed a similar distribution of severity on the basis of the GBD sequela definition and Rankin Scale categories.”
The authors state this as an assumption.
Trends in stroke incidence, mortality, and DALYs will continue as observed.
“If these trends in stroke incidence, mortality, and DALYs continue”
The authors state this as an assumption.
Trends in smoking and other stroke risk factors in the developing world will continue unchecked.
“if these trends continue and are left unchecked”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
WHO Framework for Engagement with Non-State Actors guides interactions with NGOs, private sector, foundations, and academia, seeking transparency and protecting against risks.
“In 2016, WHO member states negotiated a Framework for Engagement with Non-State Actors,192 which includes non-governmental organisations, private sector entities, philanthropic foundations, and academic institutions. The Framework guides and strengthens the ways in which WHO interacts and works with these entities, seeking to ensure “transparency, openness, inclusiveness, accountability, integrity”
From The legal determinants of health: harnessing the power of law for global health and sustainable development (2019) · cites this paper as [192]
The Discussion addresses stroke prevention and care, while Methods > Role of the funding source addresses only this study’s sponsor (page numbers unavailable). Searches for the WHO Framework for Engagement with Non-State Actors and its listed entities and principles found no passage about the framework or how it guides WHO interactions. (LLM, conf=0.78)
Experimental — accuracy not yet measuredNon-state actors can informally contribute to WHO's work and attend governing body meetings but cannot engage in actual decision-making.
“Although non-state actors can informally contribute to the Organization's work and attend governing body meetings, they are not permitted to engage in actual decision-making processes.192”
From The legal determinants of health: harnessing the power of law for global health and sustainable development (2019) · cites this paper as [192]
The paper’s Methods section discusses the study sponsor’s role in the research, not participation in WHO governance. A search for non-state actors, governing body meetings, and decision-making found no passage addressing the claim in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Opposite descriptions of whether incidence and mortality trends track together
MajorThe discussion first says incidence and mortality showed a similar pattern of decline, then says their changes did not show a strong parallel.
“the similar pattern of decline in stroke incidence and mortality suggests that changes in mortality rates are most likely to be attributable to the corresponding changes in incidence.”
“we did not note a strong parallel between changes in stroke incidence and mortality, suggesting that factors contributing to stroke incidence and mortality or their changes (including level of exposure to those factors) over time might be different.”
Conflicting significance claims for mortality decline in lower-income countries
MajorThe results describe the 20% mortality-rate decline in low-income and middle-income countries as significant, with a confidence interval that excludes zero. The discussion calls the same decline non-significant.
“Mortality rates decreased significantly in both high income (37%, 31–41) and low-income and middle-income countries (20%, 15–30).”
“our findings of the decrease in mortality in low-income and middle-income countries, although not significant, were unexpected.”
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070 · see citing works
Self-citationLim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805 · see citing works
Self-citationMurray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888 · see citing works
Self-citationVos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291 · see citing works
Self-citationHeart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292 · see citing works
Isolated Hand Paresis: A Case Series
Alstadhaug, K. B., & Sjulstad, A. S. (2013) · Cerebrovascular Diseases Extra · doi:10.1159/000350708 · Cited by 4,090 · see citing works
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · see citing works
Self-citationDanaei, G., Finucane, M. M., Lu, Y., Singh, G. M., Cowan, M. J., Paciorek, C. J., Lin, J. K., Farzadfar, F., Khang, Y.-H., Stevens, G. A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60679-x · Cited by 3,568 · see citing works
Self-citationO'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., Rangarajan, S., Islam, S., Pais, P., McQueen, M. J., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60834-3 · Cited by 3,448 · see citing works
Self-citationFeigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855 · see citing works
Self-citationGlobal atlas on cardiovascular disease prevention and control.
Mendis, S., Puska, P., & Norrving, B. G. (2011) · Virtual Defense Library (Ministerio de Defensa) · Cited by 2,691 · see citing works
Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis
Rankin, J. O. (1957) · Scottish Medical Journal · doi:10.1177/003693305700200504 · Cited by 2,491 · see citing works
Feigin, V. L., Lawes, C. M., Bennett, D. A., & Anderson, C. S. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00266-7 · Cited by 1,932 · see citing works
Self-citationAGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
Ahmad, O. B., Boschi-Pinto, C., López, A. D., Murray, C. J. L., Lozano, R., & Inoue, M. (2000) · Cited by 1,793 · see citing works
Self-citationPreventing stroke: saving lives around the world
Strong, K., Mathers, C. D., & Bonita, R. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70031-5 · Cited by 1,498 · see citing works
Salomon, J. A., Vos, T., Hogan, D. R., Gagnon, M., Naghavi, M., Mokdad, A., Begum, N., Shah, R., Karyana, M., Kosen, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61680-8 · Cited by 1,322 · see citing works
Self-citationCerebrovascular disease in the community: results of a WHO collaborative study.
Aho, K., Harmsen, P., Hatano, S., Marquardsen, J., Smirnov, V. E., & Strasser, T. (1980) · Europe PMC (PubMed Central) · Cited by 1,284 · see citing works
Recovery of motor function after stroke.
Bonita, R., & Beaglehole, R. (1988) · Stroke · doi:10.1161/01.str.19.12.1497 · Cited by 1,283 · see citing works
Danaei, G., Finucane, M. M., Lin, J. K., Singh, G. M., Paciorek, C. J., Cowan, M. J., Farzadfar, F., Stevens, G. A., Lim, S. S., Riley, L. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62036-3 · Cited by 1,239 · see citing works
Self-citationSalomon, J. A., Wang, H., Freeman, M. K., Vos, T., Flaxman, A. D., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61690-0 · Cited by 1,116 · see citing works
Self-citationGBD 2010: design, definitions, and metrics
Murray, C. J., Ezzati, M., Flaxman, A. D., Lim, S., Lozano, R., Michaud, C., Naghavi, M., Salomon, J. A., Shibuya, K., Vos, T., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61899-6 · Cited by 1,103 · see citing works
Self-citationJohnston, S. C., Mendis, S., & Mathers, C. D. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70023-7 · Cited by 977 · see citing works
Yusuf, S., Islam, S., Chow, C. K., Rangarajan, S., Dagenais, G., Diaz, R., Gupta, R., Kelishadi, R., Iqbal, R., Avezum, A., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61215-4 · Cited by 964 · see citing works
Wang, H., Dwyer-Lindgren, L., Lofgren, K. T., Rajaratnam, J. K., Marcus, J. R., Levin-Rector, A., Levitz, C. E., Lopez, A. D., & Murray, C. J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61719-x · Cited by 810 · see citing works
Self-citationAge at stroke: Temporal trends in stroke incidence in a large, biracial population
Kissela, B. M., Khoury, J. C., Alwell, K., Moomaw, C. J., Woo, D., Adeoye, O., Flaherty, M. L., Khatri, P., Ferioli, S., De Los Rios La Rosa, F., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318270401d · Cited by 743 · see citing works
Age standardization of rates: a new WHO standard (GPE discussion paper Series: No. 31)
Ahmad, O., Boschi-Pinto, C., López, A. D., Murray, C. O., Lozano, R., Inoue, M., & Ahmad, O. R. A. (2002) · Cited by 707 · see citing works
Self-citationModeling causes of death: an integrated approach using CODEm
Foreman, K. J., Lozano, R., Lopez, A. D., & Murray, C. J. (2012) · Population Health Metrics · doi:10.1186/1478-7954-10-1 · Cited by 564 · see citing works
Self-citationFarzadfar, F., Finucane, M. M., Danaei, G., Pelizzari, P. M., Cowan, M. J., Paciorek, C. J., Singh, G. M., Lin, J. K., Stevens, G. A., Riley, L. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62038-7 · Cited by 513 · see citing works
Self-citationInternational Trends in Mortality From Stroke, 1968 to 1994
Sarti, C., Rastenyte, D., Cepaitis, Z., & Tuomilehto, J. (2000) · Stroke · doi:10.1161/01.str.31.7.1588 · Cited by 451 · see citing works
The global burden of stroke and need for a continuum of care
Norrving, B. G., & D, B. M. K. M. (2013) · Neurology · doi:10.1212/wnl.0b013e3182762397 · Cited by 344 · see citing works
Redon, J., Olsen, M. H., Cooper, R. S., Zurriaga, O., Martinez-Beneito, M. A., Laurent, S., Cifkova, R., Coca, A., & Mancia, G. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr045 · Cited by 243 · see citing works
Stemming the global tsunami of cardiovascular disease
Anand, S. S., & Yusuf, S. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62346-x · Cited by 216 · see citing works
Stroke Incidence on the East Coast of Australia
Thrift, A. G., Dewey, H. M., Macdonell, R. A. L., McNeil, J. J., & Donnan, G. A. (2000) · Stroke · doi:10.1161/01.str.31.9.2087 · Cited by 198 · see citing works
HERMAN, B., Leyten, A. C. M., van Luijk, J. H., Frenken, C. W. G. M., de Coul, A. A. O., & Schulte, B. P. M. (1982) · Stroke · doi:10.1161/01.str.13.5.629 · Cited by 179 · see citing works
Putaala, J., Yesilot, N., Waje-Andreassen, U., Pitkäniemi, J., Vassilopoulou, S., Nardi, K., Odier, C., Hofgart, G., Engelter, S., Burow, A., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.662866 · Cited by 168 · see citing works
Trends in Stroke and Coronary Heart Disease in the WHO MONICA Project
Truelsen, T., Mähönen, M., Tolonen, H., Asplund, K., Bonita, R., & Vanuzzo, D. (2003) · Stroke · doi:10.1161/01.str.0000069724.36173.4d · Cited by 157 · see citing works
Self-citationSarti, C., Stegmayr, B., Tolonen, H., Mähönen, M., Tuomilehto, J., & Asplund, K. (2003) · Stroke · doi:10.1161/01.str.0000081224.15480.52 · Cited by 138 · see citing works
Medin, J., Nordlund, A., & Ekberg, K. (2004) · Stroke · doi:10.1161/01.str.0000125866.78674.96 · Cited by 135 · see citing works
Trends in Substance Abuse Preceding Stroke Among Young Adults: A Population-Based Study
de los Ríos, F., Kleindorfer, D. O., Khoury, J., Broderick, J. P., Moomaw, C. J., Adeoye, O., Flaherty, M. L., Khatri, P., Woo, D., Alwell, K., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.667808 · Cited by 130 · see citing works
Sidney, S., Rosamond, W. D., Howard, V. J., & Luepker, R. V. (2012) · Circulation · doi:10.1161/circulationaha.112.155911 · Cited by 126 · see citing works
The Decline in Stroke Mortality: Exploration of Future Trends in 7 Western European Countries
Kunst, A. E., Amiri, M., & Janssen, F. (2011) · Stroke · doi:10.1161/strokeaha.110.599712 · Cited by 118 · see citing works
Remarkable Decline in Ischemic Stroke Mortality is Not Matched by Changes in Incidence
Vaartjes, I., O’Flaherty, M., Capewell, S., Kappelle, J., & Bots, M. (2013) · Stroke · doi:10.1161/strokeaha.112.677724 · Cited by 103 · see citing works
Feigin, V., & Vander Hoorn, S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16436-2 · Cited by 94 · see citing works
Self-citationProgressive Decline in Stroke Mortality in Brazil From 1980 to 1982, 1990 to 1992, and 2000 to 2002
André, C., Curioni, C. C., Braga da Cunha, C., & Veras, R. (2006) · Stroke · doi:10.1161/01.str.0000244768.46566.73 · Cited by 71 · see citing works
Ethnic and Geographic Variation in Stroke Mortality Trends
Gillum, R. F., Kwagyan, J., & Obisesan, T. O. (2011) · Stroke · doi:10.1161/strokeaha.111.625343 · Cited by 61 · see citing works
Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study
Alzamora, M. T., Sorribes, M., Heras, A., Vila, N., Vicheto, M., Forés, R., Sánchez-Ojanguren, J., Sancho, A., & Pera, G. (2008) · BMC Neurology · doi:10.1186/1471-2377-8-5 · Cited by 57 · see citing works
Stroke Prevention in the Developing World
Feigin, V. L., & Krishnamurthi, R. (2011) · Stroke · doi:10.1161/strokeaha.110.596858 · Cited by 48 · see citing works
Self-citationMethodology of the Global and Regional Burden of Stroke Study
(2012) · Neuroepidemiology · doi:10.1159/000334744 · Cited by 39 · see citing works
Self-citationStringhini, S., Sinon, F., Didon, J., Gedeon, J., Paccaud, F., & Bovet, P. (2012) · Stroke · doi:10.1161/strokeaha.112.658468 · Cited by 31 · see citing works
An epidemic of risk factors for cardiovascular disease
Lancet, T. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60182-7 · Cited by 26 · see citing works
Cairncross, F. (2007) · Nature · doi:10.1038/448875a · Cited by 15 · see citing works
Challenging age-old ideas about stroke
Neurology, T. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70274-0 · Cited by 2 · see citing works
Flagged first, then by citations
2 of the 54 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · see citing works
Heart Disease and Stroke Statistics—2015 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., de Ferranti, S., Després, J.-P., Fullerton, H. J., Howard, V. J., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000152 · Cited by 5,797 · see citing works
Heart disease and stroke statistics-2018 update: a report from the american heart association
Benjamin, E. J., Virani, S. S., Callaway, C. W., Chamberlain, A. M., Chang, A. R., Cheng, S., Chiuve, S. E., Cushman, M., Delling, F. N., Deo, R., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000558 · Cited by 7,146 · see citing works
Heart Disease and Stroke Statistics—2016 Update: A Report From the American Heart Association
Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M., Das, S. R., de Ferranti, S., Després, J.-P., Fullerton, H. J., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000350 · Cited by 6,596 · see citing works
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414 · see citing works
Self-citationEstimating the global incidence of traumatic brain injury
Dewan, M. C., Rattani, A., Gupta, S., Baticulon, R. E., Hung, Y., Punchak, M. A., Agrawal, A., Adeleye, A. O., Shrime, M. G., Rubiano, A. M., et al. (2018) · Journal of neurosurgery · doi:10.3171/2017.10.jns17352 · Cited by 3,354 · see citing works
“238 As described by Feigin et al., 82 less rigorous study quality was permitted for studies from LMICs, from which data would otherwise be unavailable.”
Feigin, V. L., Norrving, B., & Mensah, G. A. (2017) · Circulation Research · doi:10.1161/circresaha.116.308413 · Cited by 2,184 · see citing works
Self-citationFeigin, V. L., Roth, G. A., Naghavi, M., Parmar, P., Krishnamurthi, R., Chugh, S., Mensah, G. A., Norrving, B., Shiue, I., Ng, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30073-4 · Cited by 1,691 · see citing works
Self-citationStroke in China: advances and challenges in epidemiology, prevention, and management
Wu, S., Wu, B., Liu, M., Chen, Z., Wang, W., Anderson, C. S., Sandercock, P. A., Wang, Y., Huang, Y., Cui, L., et al. (2019) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30500-3 · Cited by 1,593 · see citing works
Self-citationWendelboe, A. M., & Raskob, G. E. (2016) · Circulation Research · doi:10.1161/circresaha.115.306841 · Cited by 1,519 · see citing works
Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
Feigin, V. L., Krishnamurthi, R., Parmar, P. G. K., Norrving, B., Mensah, G. A., Bennett, D., Barker-Collo, S. L., Moran, A. E., Sacco, R. L., Truelsen, T., et al. (2015) · Neuroepidemiology · doi:10.1159/000441085 · Cited by 1,313 · see citing works
Self-citationHankey, G. J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30962-x · Cited by 1,311 · see citing works
Chamorro, Á., Dirnagl, U., Urra, X., & Planas, A. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00114-9 · Cited by 1,198 · see citing works
Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H. R., Gallus, A. S., Hunt, B. J., Hylek, E. M., Kakkar, A. K., Konstantinides, S., McCumber, M. D., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304488 · Cited by 1,160 · see citing works
Virtual reality for stroke rehabilitation
Laver, K., George, S., Thomas, S., Deutsch, J. E., & Crotty, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008349.pub3 · Cited by 1,136 · see citing works
Reducing the Global Burden of Cardiovascular Disease, Part 1
Joseph, P. G., Leong, D. P., McKee, M., Anand, S. S., Schwalm, J.-D., Teo, K. K., Mente, A., & Yusuf, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.308903 · Cited by 1,133 · see citing works
Stroke: a global response is needed
Johnson, W., Onuma, O., Owolabi, M., & Sachdev, S. (2016) · Bulletin of the World Health Organization · doi:10.2471/blt.16.181636 · Cited by 1,022 · see citing works
Etminan, N., Chang, H.-S., Hackenberg, K., de Rooij, N. K., Vergouwen, M. D. I., Rinkel, G. J. E., & Algra, A. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2019.0006 · Cited by 919 · see citing works
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y., Zhang, H., Pang, X., Chen, L., Zhou, L., Chen, M., Tian, D., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 971 · see citing works
Self-citationThe therapeutic potential of resveratrol: a review of clinical trials
Berman, A. Y., Motechin, R. A., Wiesenfeld, M. Y., & Holz, M. K. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0038-6 · Cited by 895 · see citing works
A human brain vascular atlas reveals diverse mediators of Alzheimer’s risk
Yang, A. C., Vest, R. T., Kern, F., Lee, D. P., Agam, M., Maat, C. A., Losada, P. M., Chen, M. B., Schaum, N., Khoury, N., et al. (2022) · Nature · doi:10.1038/s41586-021-04369-3 · Cited by 797 · see citing works
Wafa, H. A., Wolfe, C. D. A., Emmett, E. S., Roth, G. A., Johnson, C. O., & Wang, Y. (2020) · Stroke · doi:10.1161/strokeaha.120.029606 · Cited by 825 · see citing works
Virtual reality for stroke rehabilitation
Laver, K. E., Lange, B., George, S., Deutsch, J. E., Saposnik, G., & Crotty, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008349.pub4 · Cited by 800 · see citing works
Steiner, T., Salman, R. A., Beer, R., Christensen, H., Cordonnier, C., Csiba, L., Forsting, M., Harnof, S., Klijn, C. J. M., Krieger, D. W., et al. (2014) · International Journal of Stroke · doi:10.1111/ijs.12309 · Cited by 814 · see citing works
† (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70102-0 · Cited by 800 · see citing works
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M. S., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 784 · see citing works
Short term exposure to air pollution and stroke: systematic review and meta-analysis
Shah, A. S. V., Lee, K. K., McAllister, D. A., Hunter, A., Nair, H., Whiteley, W., Langrish, J. P., Newby, D. E., & Mills, N. L. (2015) · BMJ · doi:10.1136/bmj.h1295 · Cited by 870 · see citing works
Repetitive task training for improving functional ability after stroke
French, B., Thomas, L. H., Coupe, J., McMahon, N. E., Connell, L., Harrison, J., Sutton, C., Tishkovskaya, S., & Watkins, C. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006073.pub3 · Cited by 746 · see citing works
Traumatic spinal injury: global epidemiology and worldwide volume
Kumar, R., Lim, J., Mekary, R. A., Rattani, A., Dewan, M. C., Sharif, S. Y., Osorio-Fonseca, E., & Park, K. B. (2018) · World Neurosurgery · doi:10.1016/j.wneu.2018.02.033 · Cited by 657 · see citing works
Dagenais, G. R., Leong, D. P., Rangarajan, S., Lanas, F. T., López-Jaramillo, P. A., Gupta, R., Díaz, R., Avezum, Á., Oliveira, G. B. F., Wielgosz, A. T., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32007-0 · Cited by 657 · see citing works
Amini, M., Zayeri, F., & Salehi, M. (2021) · BMC Public Health · doi:10.1186/s12889-021-10429-0 · Cited by 636 · see citing works
van der Flier, W. M., Skoog, I. G., Schneider, J. A., Pantoni, L., Mok, V., Chen, C., & Scheltens, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.3 · Cited by 600 · see citing works
Constraint-induced movement therapy after stroke
Kwakkel, G., Veerbeek, J. M., van Wegen, E. E. H., & Wolf, S. L. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70160-7 · Cited by 594 · see citing works
Post-stroke depression: A 2020 updated review
Medeiros, G. C., Roy, D., Kontos, N. J., & Beach, S. R. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.06.011 · Cited by 590 · see citing works
Post-stroke depression: Mechanisms and pharmacological treatment
Villa, R. F., Ferrari, F., & Moretti, A. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.11.005 · Cited by 538 · see citing works
Avan, A., Digaleh, H., Di Napoli, M., Stranges, S., Behrouz, R., Shojaeianbabaei, G., Amiri, A., Tabrizi, R., Mokhber, N., Spence, J. D., et al. (2019) · BMC Medicine · doi:10.1186/s12916-019-1397-3 · Cited by 514 · see citing works
Pu, L., Wang, L., Zhang, R., Zhao, T., Jiang, Y., & Han, L. (2023) · Stroke · doi:10.1161/strokeaha.122.040073 · Cited by 525 · see citing works
Epidemiology of stroke in Europe and trends for the 21st century
Béjot, Y., Bailly, H., Durier, J., & Giroud, M. (2016) · La Presse Médicale · doi:10.1016/j.lpm.2016.10.003 · Cited by 510 · see citing works
Sun, M.-S., Jin, H., Sun, X., Huang, S., Zhang, F.-L., Guo, Z., & Yang, Y. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3804979 · Cited by 511 · see citing works
Thrift, A. G., Cadilhac, D. A.-M., Thayabaranathan, T., Howard, G., Howard, V. J., Rothwell, P. M., & Donnan, G. A. (2013) · International Journal of Stroke · doi:10.1111/ijs.12245 · Cited by 487 · see citing works
Thrombosis: a major contributor to the global disease burden
Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H. R., Gallus, A. S., Hunt, B. J., Hylek, E. M., Kakkar, A. K., Konstantinides, S., McCumber, M. D., et al. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12698 · Cited by 489 · see citing works
Prevalence of diabetes and its effects on stroke outcomes: A meta‐analysis and literature review
Lau, L., Lew, J., Borschmann, K., Thijs, V., & Ekinci, E. I. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12932 · Cited by 460 · see citing works
Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke
Hu, X.-M., Silva, T. D. D., Chen, J., & Faraci, F. (2017) · Circulation Research · doi:10.1161/circresaha.116.308427 · Cited by 378 · see citing works
Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update
Adeoye, O. M., Nyström, K. V., Yavagal, D. R., Luciano, J. M., Nogueira, R. G., Zorowitz, R. D., Khalessi, A. A., Bushnell, C., Barsan, W. G., Panagos, P. D., et al. (2019) · Stroke · doi:10.1161/str.0000000000000173 · Cited by 454 · see citing works
Global hydrocephalus epidemiology and incidence: systematic review and meta-analysis
Dewan, M. C., Rattani, A., Mekary, R. A., Glancz, L. J., Yunusa, I. U., Baticulon, R. E., Fieggen, G. A. G., Wellons, J. C., Park, K. B., & Warf, B. C. (2018) · Journal of neurosurgery · doi:10.3171/2017.10.jns17439 · Cited by 450 · see citing works
Thrift, A. G., Thayabaranathan, T., Howard, G., Howard, V. J., Rothwell, P. M., Feigin, V. L., Norrving, B. G., Donnan, G. A., & Cadilhac, D. A.-M. (2016) · International Journal of Stroke · doi:10.1177/1747493016676285 · Cited by 440 · see citing works
Self-citationHenderson, T. A., & Morries, L. D. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s78182 · Cited by 432 · see citing works
Gut Microbiota and Complications of Type-2 Diabetes
Iatcu, O. C., Steen, A., & Covașă, M. (2021) · Nutrients · doi:10.3390/nu14010166 · Cited by 433 · see citing works
Owolabi, M. O., Akarolo-Anthony, S. N., Akinyemi, R., Arnett, D. K., Gebregziabher, M., Jenkins, C. H., Tiwari, H. K., Arulogun, O., Akpalu, A. K., Sarfo, F., et al. (2015) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2015-038 · Cited by 424 · see citing works
Kamel, H., & Healey, J. S. (2017) · Circulation Research · doi:10.1161/circresaha.116.308407 · Cited by 435 · see citing works
Stroke Epidemiology in South, East, and South-East Asia: A Review
Venketasubramanian, N., Yoon, B. W., Pandian, J. D., & Navarro, J. C. (2017) · Journal of Stroke · doi:10.5853/jos.2017.00234 · Cited by 418 · see citing works
Self-citationMitchell, A. J., Sheth, B., Gill, J., Yadegarfar, M., Stubbs, B., Yadegarfar, M., & Meader, N. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.04.001 · Cited by 414 · see citing works
The effects of socioeconomic status on stroke risk and outcomes
Marshall, I. J., Wang, Y., Crichton, S. L., McKevitt, C., Rudd, A. G., & Wolfe, C. D. A. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00200-8 · Cited by 408 · see citing works
Kalladka, D., Sinden, J. D., Pollock, K., Haig, C. E., McLean, J., Smith, W., McConnachie, A., Santosh, C., Bath, P. M., Dunn, L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30513-x · Cited by 420 · see citing works
Saposnik, G., Cohen, L. G., Mamdani, M., Pooyania, S., Ploughman, M., Cheung, D., Shaw, J., Hall, J., Nord, P., Dukelow, S. P., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30121-1 · Cited by 411 · see citing works
Motor compensation and its effects on neural reorganization after stroke
Jones, T. A. (2017) · Nature reviews. Neuroscience · doi:10.1038/nrn.2017.26 · Cited by 380 · see citing works
Cell Death Mechanisms in Stroke and Novel Molecular and Cellular Treatment Options
Şekerdağ, E., Solaroğlu, İ., & Özdemir, Y. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302115544 · Cited by 373 · see citing works
Li, X., Kong, X.-M., Yang, C., Cheng, Z., Lv, J.-J., Guo, H. Y., & Liu, X. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102758 · Cited by 408 · see citing works
Crichton, S. L., Bray, B., McKevitt, C., Rudd, A. G., & Wolfe, C. D. A. (2016) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-313361 · Cited by 361 · see citing works
Krishnamurthi, R., Moran, A. E., Feigin, V., Barker-Collo, S., Norrving, B., Mensah, G., Taylor, S., Naghavi, M., Forouzanfar, M., Nguyen, G., et al. (2015) · Neuroepidemiology · doi:10.1159/000441098 · Cited by 314 · see citing works
Self-citationAnticoagulants for acute ischaemic stroke
Sandercock, P. A., Counsell, C. E., & Kamal, A. K. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000024.pub3 · Cited by 372 · see citing works
Brain–machine interfaces in neurorehabilitation of stroke
Soekadar, S. R., Birbaumer, N., Slutzky, M. W., & Cohen, L. G. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.11.025 · Cited by 335 · see citing works
Human-sized magnetic particle imaging for brain applications
Graeser, M., Thieben, F., Szwargulski, P., Werner, F., Gdaniec, N., Boberg, M., Griese, F., Möddel, M., Ludewig, P., van de Ven, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09704-x · Cited by 339 · see citing works
Contributions of risk factors and medical care to cardiovascular mortality trends
Ezzati, M., Obermeyer, Z., Tzoulaki, I., Mayosi, B. M., Elliott, P., & Leon, D. A. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.82 · Cited by 336 · see citing works
Self-citationAcute ischemic stroke therapy overview
Catanese, L., Tarsia, J., & Fisher, M. (2017) · Circulation Research · doi:10.1161/circresaha.116.309278 · Cited by 341 · see citing works
Gostin, L. O., Monahan, J. T., Kaldor, J., DeBartolo, M., Friedman, E. A., Gottschalk, K., Kim, S. C., Alwan, A., Binagwaho, A., Burci, G. L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30233-8 · Cited by 338 · see citing works
Targeting NMDA receptors in stroke: new hope in neuroprotection
Wu, Q. J., & Tymianski, M. (2018) · Molecular Brain · doi:10.1186/s13041-018-0357-8 · Cited by 338 · see citing works
Danger signals in stroke and their role on microglia activation after ischemia
Gülke, E., Gelderblom, M., & Magnus, T. (2018) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756286418774254 · Cited by 321 · see citing works
Morone, G., Paolucci, S., Cherubini, A., Angelis, D. D., Venturiero, V., Coiro, P., & Iosa, M. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114102 · Cited by 299 · see citing works
Pellegrini, E., Ballerini, L., Hernández, M. D. C. V., Chappell, F. M., González‐Castro, V., Anblagan, D., Danso, S., Maniega, S. M., Job, D. E., Pernet, C. R., et al. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.07.004 · Cited by 297 · see citing works
“2018 of death and commonest cause of dependency in adults worldwide [2].”
BackgroundThrombosis: A major contributor to global disease burden
Raskob, G. E., Angchaisuksiri, P., Blanco, A. N., Buller, H. R., Gallus, A. S., Hunt, B. J., Hylek, E. M., Kakkar, A. K., Konstantinides, S., McCumber, M. D., et al. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.08.014 · Cited by 304 · see citing works
Pindus, D. M., Mullis, R., Lim, L., Wellwood, I., Rundell, A. V., Aziz, N. A. A., & Mant, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192533 · Cited by 285 · see citing works
Kato, E. T., Giugliano, R. P., Ruff, C. T., Koretsune, Y., Yamashita, T., Kiss, R. G., Nordio, F., Murphy, S. A., Kimura, T., Jin, J., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003432 · Cited by 288 · see citing works
A large, open source dataset of stroke anatomical brain images and manual lesion segmentations
Liew, S.-L., Anglin, J. M., Banks, N. W., Sondag, M., Ito, K. L., Kim, H., Chan, J., Ito, J., Jung, C., Khoshab, N., et al. (2018) · Scientific Data · doi:10.1038/sdata.2018.11 · Cited by 283 · see citing works
Saver, J. L., Goyal, M., Bonafe, A., et al. (2015) · International Journal of Stroke · doi:10.1111/ijs.12459 · Cited by 279 · see citing works
Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives
Béjot, Y., Daubail, B., & Giroud, M. (2015) · Revue Neurologique · doi:10.1016/j.neurol.2015.07.013 · Cited by 273 · see citing works
Bai, J., & Lyden, P. D. (2015) · International Journal of Stroke · doi:10.1111/ijs.12434 · Cited by 272 · see citing works
Recurrent Ischemic Stroke – A Systematic Review and Meta-Analysis
Kolmos, M., Christoffersen, L. C., & Kruuse, C. R. (2021) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2021.105935 · Cited by 269 · see citing works
Acupuncture for stroke rehabilitation
Yang, A., Wu, H. M., Tang, J.-L., Li, X., Yang, M. J., & Liu, G. J. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004131.pub3 · Cited by 271 · see citing works
Li, P., Stetler, R. A., Leak, R. K., Shi, Y., Li, Y., Yu, W., Bennett, M. V. L., & Chen, J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.011 · Cited by 260 · see citing works
Post‐stroke cognitive decline: an update and perspectives for clinical research
Brainin, M., Tuomilehto, J., Heiss, W., Bornstein, N. M., Bath, P. M., Teuschl, Y., Richard, E., Guekht, A. B., Quinn, T. J., & the Post Stroke Cognition Study Group (2014) · European Journal of Neurology · doi:10.1111/ene.12626 · Cited by 257 · see citing works
Evidence of perceived psychosocial stress as a risk factor for stroke in adults: a meta-analysis
Booth, J., Connelly, L., Lawrence, M., Chalmers, C., Joice, S. A., Becker, C., & Dougall, N. J. (2015) · BMC Neurology · doi:10.1186/s12883-015-0456-4 · Cited by 252 · see citing works
The Case for Diet: A Safe and Efficacious Strategy for Secondary Stroke Prevention
Dearborn, J. L., Urrutia, V., & Kernan, W. N. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00001 · Cited by 255 · see citing works
Prevention of stroke: a strategic global imperative
Feigin, V. L., Norrving, B., George, M. G., Foltz, J. L., Roth, G. A., & Mensah, G. A. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.107 · Cited by 250 · see citing works
Self-citationConnexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
Leybaert, L., Lampe, P. D., Dhein, S., Kwak, B. R., Ferdinandy, P., Beyer, E. C., Laird, D. W., Naus, C. C. G., Green, C. R., & Schulz, R. (2017) · Pharmacological Reviews · doi:10.1124/pr.115.012062 · Cited by 244 · see citing works
Kim, J. Y., Kang, K., Kang, J., Koo, J., Kim, D., Kim, B. J., Kim, W., Kim, E. G., Kim, J. G., Kim, J., et al. (2018) · Journal of Stroke · doi:10.5853/jos.2018.03125 · Cited by 244 · see citing works
Restoring brain function after stroke — bridging the gap between animals and humans
Ward, N. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.34 · Cited by 242 · see citing works
The therapeutic potential of the mesenchymal stem cell secretome in ischaemic stroke
Cunningham, C. J., Redondo-Castro, E., & Allan, S. M. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18776802 · Cited by 242 · see citing works
An International Standard Set of Patient-Centered Outcome Measures After Stroke
Salinas, J., Sprinkhuizen, S. M., Ackerson, T., Bernhardt, J. A., Davie, C., George, M. G., Gething, S., Kelly, A. G., Lindsay, P., Liu, L., et al. (2015) · Stroke · doi:10.1161/strokeaha.115.010898 · Cited by 233 · see citing works
Corriveau, R. A., Bosetti, F., Emr, M., Gladman, J. T., Koenig, J. I., Moy, C. S., Pahigiannis, K., Waddy, S. P., & Koroshetz, W. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0334-7 · Cited by 240 · see citing works
Improving post-stroke recovery: the role of the multidisciplinary health care team
Clarke, D. J., & Förster, A. (2015) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s68764 · Cited by 234 · see citing works
Neuropsychiatric sequelae of stroke
Ferro, J. M., Caeiro, L., & Figueira, M. L. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.46 · Cited by 237 · see citing works
Aminov, A., Rogers, J. M., Middleton, S., Caeyenberghs, K., & Wilson, P. H. (2018) · Journal of NeuroEngineering and Rehabilitation · doi:10.1186/s12984-018-0370-2 · Cited by 236 · see citing works
Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes
Ornello, R., Degan, D., Tiseo, C., Carmine, C. D., Perciballi, L., Pistoia, F., Carolei, A., & Sacco, S. (2018) · Stroke · doi:10.1161/strokeaha.117.020031 · Cited by 235 · see citing works
Cerebral Microbleeds Are Associated With an Increased Risk of Stroke
Akoudad, S., Portegies, M. L. P., Koudstaal, P. J., Albert Hofman, D., van der Lugt, A., Ikram, M. A., & Vernooij, M. W. (2015) · Circulation · doi:10.1161/circulationaha.115.016261 · Cited by 225 · see citing works
Sitting and Activity Time in People With Stroke
English, C., Healy, G. N., Coates, A. M., Lewis, L. K., Olds, T., & Bernhardt, J. A. (2015) · Physical Therapy · doi:10.2522/ptj.20140522 · Cited by 226 · see citing works
Chassagnon, I. R., McCarthy, C. A., Chin, Y. K. ‐., Pineda, S. S., Keramidas, A., Mobli, M., Pham, V., Silva, T. M. D., Lynch, J. W., Widdop, R. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614728114 · Cited by 230 · see citing works
Magnetic Particle Imaging for Real-Time Perfusion Imaging in Acute Stroke
Ludewig, P., Gdaniec, N., Sedlacik, J., Forkert, N. D., Szwargulski, P., Graeser, M., Adam, G., Kaul, M. G., Krishnan, K. M., Ferguson, R. M., et al. (2017) · ACS Nano · doi:10.1021/acsnano.7b05784 · Cited by 225 · see citing works
Neurotechnology-aided interventions for upper limb motor rehabilitation in severe chronic stroke
Coscia, M., Wessel, M. J., Chaudary, U., Millán, J. D. R., Micera, S., Guggisberg, A. G., Vuadens, P., Donoghue, J. P., Birbaumer, N., & Hummel, F. C. (2019) · Brain · doi:10.1093/brain/awz181 · Cited by 217 · see citing works
Feng, Z., Yu, X., Jiang, M., Zhu, L. J., Zhang, Y., Yang, W., Wang, X., Li, G., & Qian, J. (2019) · Theranostics · doi:10.7150/thno.31332 · Cited by 210 · see citing works
- Authors
- Feigin, V. L., Forouzanfar, M. H., Krishnamurthi, R., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L., Truelsen, T., O'Donnell, M., Venketasubramanian, N., Barker-Collo, S., Lawes, C. M. M., Wang, W., Shinohara, Y., Witt, E., Ezzati, M., Naghavi, M., & Murray, C.
- Affiliations
- Auckland University of Technology (NZ)
- University of Washington (US)
- National Institutes of Health (US)
- National Health Service (GB)
- University of Oxford (GB)
- Columbia University Irving Medical Center (US)
- University of Miami (US)
- Washington State Institute for Public Policy (US)
- Herlev Hospital (DK)
- Ollscoil na Gaillimhe – University of Galway (IE)
- University of Auckland (NZ)
- Capital Medical University (CN)
- Tachikawa Hospital (JP)
- Imperial College London (GB)
- Corresponding author
- Feigin, Valery L
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 383
- Issue
- 9913
- Pages
- 245-255
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4181600
- OpenAlex
- W2155477484
- Semantic Scholar
- 40299da354638a7c56c5ce2515577475d0b1dd63
- Cited by
- 3,899
- References
- 54
- Citations by year
- 2026: 114 · 2025: 184 · 2024: 245 · 2023: 261 · 2022: 302 · 2021: 364 · 2020: 416 · 2019: 424 · 2018: 400 · 2017: 411 · 2016: 346 · 2015: 293 · 2014: 126 · 2013: 7 · 2012: 1
- FWCI
- 30.49
- Type
- journal article
- Language
- en
- Update notices
- erratum (2014-01-18)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- National University of Singapore (submittedVersion)
- Funders
- University of Miami
- National Heart, Lung, and Blood Institute (K08HL089675)
- Topics
- Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Health Professions › Health Information Management › Global Health and Epidemiology
- Keywords
- stroke, global burden of disease, stroke incidence, stroke prevalence, stroke mortality, disability-adjusted life years, stroke survivors, epidemiological trends, high-income countries, low- and middle-income countries, regional variation, age-standardized rates, Global Burden of Disease Study 2010, disability burden
- MeSH terms
- Age Factors, Developing Countries, Humans, Mortality, Global Health, Cost of Illness, Developed Countries, Quality-Adjusted Life Years, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review